Zak Mir talks to Dr Eric Leire, CEO Genflow Biosciences, in the wake of the company, which is rapidly becoming the major European exponent in the successful development of therapeutic longevity solutions for the prevention of age-related diseases, announcing it has raised, through its broker Capital Plus Partners, £715,000. This was to add and broaden the number of institutional investors in Genflow, including Premier Miton.
Author
